Merck KGaA ١ أبريل ٢٠٢٦ Merck Completes Acquisition of JSR Life Sciences’ Chromatography Business - Merck Group
FierceBiotech ٢٥ مارس ٢٠٢٦ Merck, girding for Keytruda cliff, flies toward promising CML asset with $6.7B Terns acquisition
Endpoints News ٢٥ مارس ٢٠٢٦ Merck to buy Terns for $6.7B, taking a leukemia drug that could challenge Novartis' Scemblix
Endpoints News ٢٤ مارس ٢٠٢٦ Merck partners with Flagship startup Quotient to search for genetic clues to IBD
FierceBiotech ٦ مارس ٢٠٢٦ Merck KGaA drops pipeline assets from SpringWorks buyout, Hengrui licensing deal
BioPharma Dive ١٢ فبراير ٢٠٢٦ Sanofi, looking for more ‘rigor,’ swaps CEO Hudson for ex-Merck KGaA chief Garijo